A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1997
12/16/1997	US5697901 Gene delivery by microneedle injection
12/11/1997	WO1997046710A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof
12/11/1997	WO1997046693A1 Virus-like particles useful as a vector for delivering nucleic acid
12/11/1997	WO1997046688A1 Lipid kinase
12/11/1997	WO1997046687A1 Vectors comprising sar elements
12/11/1997	WO1997046686A2 Tumor necrosis factor-related polypeptide
12/11/1997	WO1997046685A1 Polynucleotides encoding secreted proteins from human dendritic cells
12/11/1997	WO1997046684A1 Non-activated receptor complex proteins and uses thereof
12/11/1997	WO1997046683A2 Polynucleotides encoding secreted proteins
12/11/1997	WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins
12/11/1997	WO1997046680A1 Dna encoding dp. 75 and a process for its use
12/11/1997	WO1997046679A1 Cyclin-c variants, and diagnostic and therapeutic uses thereof
12/11/1997	WO1997046673A2 Inhibition of hiv-1 replication by antisense rna expression
12/11/1997	WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes
12/11/1997	WO1997046671A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	WO1997046663A1 Interleukin-1 beta converting enzyme like apoptotic protease-6
12/11/1997	WO1997046570A1 Oligoribonucleotides and ribonucleases for cleaving rna
12/11/1997	WO1997046263A1 Il-12 gene therapy of tumors
12/11/1997	WO1997046257A1 A method for enhancing long-term memory in a subject and uses thereof
12/11/1997	WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
12/11/1997	WO1997046253A2 Immunotherapy for autoimmune disease
12/11/1997	WO1997046223A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
12/11/1997	WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer
12/11/1997	CA2257389A1 Virus-like particles useful as a vector for delivering nucleic acid
12/11/1997	CA2257117A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof
12/11/1997	CA2257074A1 A method for enhancing long-term memory in a subject and uses thereof
12/11/1997	CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer
12/11/1997	CA2256522A1 Polynucleotides encoding secreted proteins
12/11/1997	CA2256520A1 Polynucleotides encoding secreted proteins from human dendritic cells
12/11/1997	CA2256484A1 Vectors comprising sar elements
12/11/1997	CA2256464A1 Tumor necrosis factor-related polypeptide
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	CA2254819A1 Inhibition of hiv-1 replication by antisense rna expression
12/11/1997	CA2228444A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
12/10/1997	EP0811696A2 Method to obtain nucleotide sequence using randomly primed amplification
12/10/1997	EP0811688A2 Staphylococcus aureus RNase P
12/10/1997	EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
12/10/1997	EP0811073A2 Methods and compositions for administering gene therapy vectors
12/10/1997	EP0811071A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
12/10/1997	EP0811069A1 Chimeric adenoviral fiber protein and methods of using same
12/10/1997	EP0811066A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/10/1997	EP0811062A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
12/10/1997	EP0811061A1 Multiple-tumor aberrant growth genes
12/10/1997	EP0811060A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
12/10/1997	EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1
12/10/1997	EP0811057A1 Viral preparations, vectors, immunogens, and vaccines
12/10/1997	EP0810882A1 Methods and compositions for regulation of cd28 expression
12/10/1997	EP0810881A1 Delivery of therapeutic agents by gene therapy
12/10/1997	EP0810874A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
12/10/1997	EP0440744B1 Products and methods for controlling the suppression of the neoplastic phenotype
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167504A Tetracycline-regulated transcriptional modulators
12/10/1997	CN1167149A Method of modifying gene for changing its expression state
12/09/1997	US5696248 Gene expression inhibitor, as probes for detecting nucleic acids, as viricides treating viral disease caused by htlv, influenza, hepatitis virus, papilloma virus
12/09/1997	US5696076 5-lipoxygenase-activating protein II
12/09/1997	US5695995 Neurogenic differentiation (neurod) genes
12/09/1997	US5695991 A complex between a virus the cell binding receptor of which has been inactivated and an antibody able to interact with specific antigen; antigen has ability to mediate entrance into mammalian cells
12/09/1997	US5695932 Telomerase activity assays for diagnosing pathogenic infections
12/09/1997	US5695755 Peripheralization of hematopoietic stem cells
12/04/1997	WO1997045550A2 Mini-adenoviral vector
12/04/1997	WO1997045538A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
12/04/1997	WO1997045528A2 Mammalian tolloid-like gene and protein
12/04/1997	WO1997045437A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	WO1997045144A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045142A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997045106A1 Identification of genes altered in multiple myeloma
12/04/1997	WO1997045069A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	WO1997041150A3 Gene therapy for mitochondrial dna deffects using peptide nucleic acids
12/04/1997	CA2257148A1 Mini-adenoviral vector
12/04/1997	CA2256900A1 Cationic polymer/lipid nucleic acid delivery vehicles
12/04/1997	CA2256577A1 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2256455A1 Identification of genes altered in multiple myeloma
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2256358A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	CA2255941A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	CA2253818A1 Mammalian tolloid-like gene and protein
12/03/1997	EP0809705A1 Nucleic acid-containing composition, preparation and use thereof
12/03/1997	EP0809704A1 Method for preparing a recombinant adenovirus genome
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809516A1 Medicinal combination useful for in vivo exogenic transfection and expression
12/03/1997	EP0809500A1 Novel glucocorticoid response elements
12/03/1997	EP0746343A4 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE -i(IN VIVO) OR -i(EX VIVO)
12/03/1997	CN1166837A Chromosome 21 gene marker, compositions and methods using same
12/03/1997	CN1166788A Genetic material containing composition
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693763 Antibodies to human carcinoma antigen
12/02/1997	US5693622 By injecting a non-integrating dna sequence operably linked to a promoter in the absence of transfection-facilitating proteins, viral particles, liposomal formulations, charged lipids, and calcium phosphate precipitating agents
12/02/1997	US5693532 Respiratory syncytial virus ribozymes
12/02/1997	US5693530 Recombinant vectors; vaccines
12/02/1997	US5693522 Anti-cancer immunotherapeutics
12/02/1997	US5693511 Immortalized human fetal osteoblastic cells
12/02/1997	US5693509 Adenovirus for delivering foreign DNA into higher eukaryotic cells
12/02/1997	US5693508 Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
12/02/1997	US5693488 Transmembrane tyrosine phosphatase, nucleic acids encoding the same, and methods of use thereof

1 ... 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 ... 870